John BreitnerJohn Breitner was recruited to the Douglas to lead a new centre for Studies on Prevention of Alzheimer’s Disease (StoP-AD). The Centre’s research program evaluates how well prevention treatments work in individuals who possess certain biomarkers thought to increase the risk of Alzheimer’s Disease. These biomarkers include biochemical changes and neuroimaging measures that appear to track the development of AD in its pre-symptomatic stages.John Breitner has authored over 200 publications and is known as an outstanding teacher. He has mentored more than 15 doctoral and post-doctoral students, almost all of whom have gone on to hold full-time academic appointments.
|
